Synthetic method of novel chiral non-cycle purine nucleoside analogue

A cyclic purine nucleoside and a synthesis method technology are applied in the field of synthesis of novel chiral acyclic purine nucleoside analogs, and can solve the problems of single structure, difficult to obtain chiral source, many reaction steps and the like

Inactive Publication Date: 2015-04-29
HENAN INST OF SCI & TECH
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The disadvantage is that the current chiral propylene oxide derivatives have a single structure, and the obtained chiral acyclic nucleosides have structural limitations
Chiral acyclic nucleosides have good biological activity, and the biological activity of acyclic nucleosides can be improved by changing the side chain. Therefore, a convenient, fast and efficient synthesis of new chiral acyclic nucleosides with potential pharmacological activity has been developed. The approach of nucleosides is based on solving the problems of many reaction steps, low yield, expensive raw materials, unavailable chiral sources, and single structure of target products in the synthesis process of such compounds. It not only has important theoretical significance, but also has a wide range of applications. Application prospect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthetic method of novel chiral non-cycle purine nucleoside analogue
  • Synthetic method of novel chiral non-cycle purine nucleoside analogue
  • Synthetic method of novel chiral non-cycle purine nucleoside analogue

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031]

[0032] Dissolve 0.1mmol of adenine and 0.05mmol of t-BuOK in 0.5mL of DMF in a reaction vessel, stir at room temperature for 2 hours, then add 0.11moL of epoxy cinnamyl alcohol, stir and react at 80°C for 12 hours, and obtain Chiral acyclic nucleoside analog, white solid, yield 90%, ee>99%. 1 H NMR (DMSO-d 6 ,400MHz)δ8.46(s,1H),8.12(s,1H),7.48(d,J=6.8,1H),7.33-7.25(M,5H),5.76(d,J=5.6Hz,1H) ,5.57(d,J=5.2Hz,1H),4.89(q,J=5.4Hz,1H),4.46-4.40(m,1H),3.33-3.28(m,1H),3.24-3.18(m,1H ) 13 CNMR (DMSO-d 6 , 100MHz) δ156.4, 152.8, 149.6, 140.5, 137.8, 129.2, 128.6, 128.1, 118.8, 72.4, 63.1, 59.4, HRMS: calcd for C 14 h 16 N 5 o 2 [M+H + ]286.1299, found 286.1293.HPLC DAICEL CHIRALCEL OJ-H, hexane / iPOH=90 / 10, λ=254nm; retention time: 43.196min(minor), 49.238min(major), 99%ee.flow rate 1.0mL / min .

Embodiment 2

[0034] The base t-BuOK in Example 1 was replaced by NaH, and other conditions remained unchanged, the yield of chiral acyclic nucleoside analogs was 88%, and the ee value was 99%.

Embodiment 3

[0036] The reaction temperature in Example 1 was changed to 110° C., and the other conditions remained unchanged, and the yield of chiral acyclic nucleoside analogs was 93%, and the ee value was 99%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a synthetic method of a novel chiral non-cycle purine nucleoside analogue. The method has the beneficial effects that reaction steps are few, a chiral source is easily available, reaction conditions are relatively mild, and meanwhile, a side chain containing two chiral centers can be constructed; reference values are provided for synthesis and application of non-cycle nucleoside drugs, and a raw material is provided for the research of novel antiviral and anti-tumor drugs; meanwhile, an effective effect is provided for the construction of other non-cycle nucleosides and analogues of the other non-cycle nucleosides; furthermore, the method has wide industrial application prospect. The method comprises the steps of firstly carrying out Sharpless epoxidation reaction to obtain epoxy propenol compounds with relatively high Ee value and yield, and opening cycles of the chiral epoxy compounds by virtue of a purine base, so as to obtain the novel non-cycle nucleoside analogue containing two chiral centers, wherein an aryl substituent is located at a site 1' of the novel non-cycle nucleoside analogue.

Description

technical field [0001] The invention relates to the technical fields of chemistry and medicine, in particular to a method for synthesizing novel chiral acyclic purine nucleoside analogues. Background technique [0002] Nucleoside compounds are composed of bases and sugar groups. They have different degrees of similarities with natural nucleosides in structure, so they have the effect of confusing real ones in vivo, which can interfere with or directly act on the biosynthesis of proteins and nucleic acids. Many nucleoside analogs are enzyme inhibitors during viral replication, which can inhibit the activity of viral DNA polymerase and reverse transcriptase and compete with nucleotides for incorporation into viral DNA chains, thereby terminating or inhibiting the elongation and synthesis of viral DNA chains , so that the replication of the virus is inhibited to play an antiviral effect, so it is possible to obtain new antiviral drugs by modifying or transforming the structure ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D473/34C07D473/16C07D239/47
CPCC07D473/34C07D239/47C07D473/16
Inventor 牛红英郭海明卫涛渠桂荣王东超谢明胜陈军冯喜兰胡林峰张家敏
Owner HENAN INST OF SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products